Report Scope & Overview:
Drug based on CAR T-Cell Market Overview:
Global Drug based on CAR T-Cell Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Drug based on CAR T-Cell Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Global Drug based on CAR T-Cell Market: By Company
• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite
• CARsgen Therapeutics (Pipeline)
• CARsgen Therapeutics
• Autolus Therapeutics
• Sorrento Therapeutics
• Mustang Bio
• Bluebird Bio
• Cellectis
• Allogene Therapeutics
• Celyad
Global Drug based on CAR T-Cell Market: By Type
• CD19-targeted
• BCMA-targeted
Global Drug based on CAR T-Cell Market: By Application
• Lymphoma
• Multiple Myeloma
Global Drug based on CAR T-Cell Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Drug based on CAR T-Cell market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Reasons to Purchase Drug based on CAR T-Cell Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Drug based on CAR T-Cell Market Study:
The objectives of Drug based on CAR T-Cell market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Drug based on CAR T-Cell market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Global Drug based on CAR T-Cell Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Drug based on CAR T-Cell Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Drug Based On CAR T-Cell Market Key Drivers
Efficacy in Hematological Cancers: CAR T-cell therapy has demonstrated high efficacy in treating certain hematological cancers, such as certain types of leukemia and lymphoma, driving its adoption as a promising treatment option.
Clinical Success and Approvals: Success in clinical trials and regulatory approvals for CAR T-cell therapies, such as Kymriah and Yescarta, have bolstered confidence in this approach and contributed to market growth.
Ongoing Research and Development: Continued investment in research and development by pharmaceutical companies and academic institutions is driving innovation in CAR T-cell therapy, expanding its application to various types of cancer.
Increased Understanding of Immunology: Advances in the understanding of immunology and tumor biology have contributed to the development of more sophisticated CAR T-cell constructs with improved targeting and persistence.
Investments and Partnerships: Pharmaceutical companies are making significant investments in CAR T-cell therapy development, often forming strategic partnerships to advance research, streamline production, and enhance commercialization.
Expanded Indications: Efforts to expand the indications for CAR T-cell therapy beyond hematological cancers to solid tumors are underway, potentially broadening its market impact.
Market Segmentations:Global Drug based on CAR T-Cell Market: By Company
• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite
• CARsgen Therapeutics (Pipeline)
• CARsgen Therapeutics
• Autolus Therapeutics
• Sorrento Therapeutics
• Mustang Bio
• Bluebird Bio
• Cellectis
• Allogene Therapeutics
• Celyad
Global Drug based on CAR T-Cell Market: By Type
• CD19-targeted
• BCMA-targeted
Global Drug based on CAR T-Cell Market: By Application
• Lymphoma
• Multiple Myeloma
Global Drug based on CAR T-Cell Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Drug based on CAR T-Cell market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • CD19-targeted • BCMA-targeted |
| By Application | • Lymphoma • Multiple Myeloma |
| Key Companies Profiled | • Novartis • Gilead Sciences • Bristol-Myers Squibb • J & J • JW Therapeutics • FOSUNKite • CARsgen Therapeutics (Pipeline) • CARsgen Therapeutics • Autolus Therapeutics • Sorrento Therapeutics • Mustang Bio • Bluebird Bio • Cellectis • Allogene Therapeutics • Celyad |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Drug based on CAR T-Cell Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Drug based on CAR T-Cell Market Study:
The objectives of Drug based on CAR T-Cell market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Drug based on CAR T-Cell market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2017-2032)
2.2 Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Global Drug based on CAR T-Cell Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2017-2023)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2023-2032)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug based on CAR T-Cell Players by Revenue
3.1.1 Global Top Drug based on CAR T-Cell Players by Revenue (2017-2023)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2017-2023)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug based on CAR T-Cell Revenue
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2022
3.5 Drug based on CAR T-Cell Key Players Head office and Area Served
3.6 Key Players Drug based on CAR T-Cell Product Solution and Service
3.7 Date of Enter into Drug based on CAR T-Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2017-2023)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2023-2032)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2017-2023)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2017-2032)
6.2 North America Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America Drug based on CAR T-Cell Market Size by Country (2017-2023)
6.4 North America Drug based on CAR T-Cell Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2017-2032)
7.2 Europe Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe Drug based on CAR T-Cell Market Size by Country (2017-2023)
7.4 Europe Drug based on CAR T-Cell Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size (2017-2032)
8.2 Asia-Pacific Drug based on CAR T-Cell Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2017-2023)
8.4 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size (2017-2032)
9.2 Latin America Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America Drug based on CAR T-Cell Market Size by Country (2017-2023)
9.4 Latin America Drug based on CAR T-Cell Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size (2017-2032)
10.2 Middle East & Africa Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2017-2023)
10.4 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type: 2017 VS 2022 VS 2032
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Growth by Application: 2017 VS 2022 VS 2032
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2017-2032)
2.2 Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Global Drug based on CAR T-Cell Market Size by Region: 2017 VS 2022 VS 2032
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2017-2023)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2023-2032)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug based on CAR T-Cell Players by Revenue
3.1.1 Global Top Drug based on CAR T-Cell Players by Revenue (2017-2023)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2017-2023)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug based on CAR T-Cell Revenue
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2022
3.5 Drug based on CAR T-Cell Key Players Head office and Area Served
3.6 Key Players Drug based on CAR T-Cell Product Solution and Service
3.7 Date of Enter into Drug based on CAR T-Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2017-2023)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2023-2032)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2017-2023)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2017-2032)
6.2 North America Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
6.3 North America Drug based on CAR T-Cell Market Size by Country (2017-2023)
6.4 North America Drug based on CAR T-Cell Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2017-2032)
7.2 Europe Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
7.3 Europe Drug based on CAR T-Cell Market Size by Country (2017-2023)
7.4 Europe Drug based on CAR T-Cell Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size (2017-2032)
8.2 Asia-Pacific Drug based on CAR T-Cell Market Growth Rate by Region: 2017 VS 2022 VS 2032
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2017-2023)
8.4 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size (2017-2032)
9.2 Latin America Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
9.3 Latin America Drug based on CAR T-Cell Market Size by Country (2017-2023)
9.4 Latin America Drug based on CAR T-Cell Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size (2017-2032)
10.2 Middle East & Africa Drug based on CAR T-Cell Market Growth Rate by Country: 2017 VS 2022 VS 2032
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2017-2023)
10.4 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2017-2023)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast